Despite a company's losses, investors can profit if they buy a promising business at the right price. Apontis Pharma's cash burn rate and runway are discussed, suggesting potential for growth despite concerns. Shareholders should monitor the company's financial health and performance.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing